You are in a "view as others" mode
Overview
Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases
Description
GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
Founded 2016
10-20
Categories
Products
Looks like GliaPharm SA has no published products yet.
Services
Looks like GliaPharm SA has no published services yet.
Company reviews
Profile Strength:
undefined%
profile
completion